Addus HomeCare (NASDAQ:ADUS) Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Addus HomeCare (NASDAQ:ADUS) released its quarterly earnings data on Monday. The company reported $1.26 earnings per share for the quarter, missing analysts’ consensus estimates of $1.35 by ($0.09), Zacks reports. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%.

Addus HomeCare Price Performance

NASDAQ ADUS traded down $0.39 during trading on Monday, hitting $108.84. The company’s stock had a trading volume of 387,696 shares, compared to its average volume of 171,011. Addus HomeCare has a fifty-two week low of $85.94 and a fifty-two week high of $136.72. The company has a market cap of $1.97 billion, a PE ratio of 24.91, a P/E/G ratio of 1.45 and a beta of 1.00. The business’s 50 day simple moving average is $125.04 and its 200-day simple moving average is $126.80.

Wall Street Analyst Weigh In

ADUS has been the subject of several research reports. Oppenheimer upped their price target on shares of Addus HomeCare from $145.00 to $150.00 and gave the stock an “outperform” rating in a research report on Friday, January 24th. Macquarie restated an “outperform” rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. JMP Securities began coverage on Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target on the stock. Stephens upped their price objective on Addus HomeCare from $143.00 to $145.00 and gave the stock an “overweight” rating in a research note on Wednesday, November 6th. Finally, StockNews.com upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Friday, January 24th. One analyst has rated the stock with a sell rating, eight have issued a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Buy” and an average price target of $134.22.

Insider Activity

In other news, CEO R Dirk Allison sold 25,000 shares of the stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the transaction, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at $1,236,257. This trade represents a 18.05 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.60% of the company’s stock.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.